- Home
- MEI vs RNAC Comparison
MEI vs RNAC Comparison
Compare MEI & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEI
- RNAC
- Stock Information
- Founded
- MEI 1946
- RNAC 2007
- Country
- MEI United States
- RNAC United States
- Employees
- MEI N/A
- RNAC N/A
- Industry
- MEI Electrical Products
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- MEI Technology
- RNAC Health Care
- Exchange
- MEI Nasdaq
- RNAC Nasdaq
- Market Cap
- MEI 464.2M
- RNAC 415.8M
- IPO Year
- MEI N/A
- RNAC 2016
- Fundamental
- Price
- MEI $6.51
- RNAC $14.54
- Analyst Decision
- MEI Buy
- RNAC Strong Buy
- Analyst Count
- MEI 3
- RNAC 8
- Target Price
- MEI $11.67
- RNAC $40.83
- AVG Volume (30 Days)
- MEI 631.8K
- RNAC 98.4K
- Earning Date
- MEI 03-05-2025
- RNAC 05-07-2025
- Dividend Yield
- MEI 8.70%
- RNAC N/A
- EPS Growth
- MEI N/A
- RNAC N/A
- EPS
- MEI N/A
- RNAC N/A
- Revenue
- MEI $1,068,300,000.00
- RNAC $38,913,000.00
- Revenue This Year
- MEI N/A
- RNAC N/A
- Revenue Next Year
- MEI $5.40
- RNAC $60.00
- P/E Ratio
- MEI N/A
- RNAC N/A
- Revenue Growth
- MEI N/A
- RNAC 49.64
- 52 Week Low
- MEI $5.84
- RNAC $11.67
- 52 Week High
- MEI $17.45
- RNAC $41.87
- Technical
- Relative Strength Index (RSI)
- MEI 31.87
- RNAC 33.21
- Support Level
- MEI $6.56
- RNAC $13.57
- Resistance Level
- MEI $7.02
- RNAC $16.79
- Average True Range (ATR)
- MEI 0.37
- RNAC 1.21
- MACD
- MEI 0.14
- RNAC -0.13
- Stochastic Oscillator
- MEI 47.01
- RNAC 18.55
About MEI Methode Electronics Inc.
Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.